Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.
about
Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseMicroglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein depositionCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseMAO-B elevation in mouse brain astrocytes results in Parkinson's pathologyResistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activationAge-related alterations in the dynamic behavior of microglia.Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.Microglia in the aging brain: relevance to neurodegenerationCyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration.Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.Pronounced microgliosis and neurodegeneration in aged rats after tau gene transferExercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease.Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptorAbsence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonismAging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammationAge and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys.Dietary curcumin supplementation attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in C57BL miceTiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation.The changing phenotype of microglia from homeostasis to diseaseMicroglia in the aging brain.Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's diseaseMicroglial aging in the healthy CNS: phenotypes, drivers, and rejuvenationNeuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionGene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation.Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsetsExacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury.A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouseInnate and adaptive immunity for the pathobiology of Parkinson's diseaseJmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson's disease.Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.Innate inflammation in Parkinson's disease.What is microglia neurotoxicity (Not)?Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.Molecular Anti-inflammatory Mechanisms of Retinoids and Carotenoids in Alzheimer's Disease: a Review of Current Evidence.Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNFThe degenerating substantia nigra as a susceptible region for gene transfer-mediated inflammation.Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
P2860
Q24794457-00DAC884-D779-4CA7-9418-598B43A8F246Q24813664-9310ADB2-6165-4B42-BA49-BEB8EF5CC3DFQ26849232-F34F9910-AF07-48C4-ABB6-C92CF9FE87B3Q27301926-4D6B9749-B8EC-465B-931B-93E13DFC98A3Q28477043-8873A152-6119-42ED-AAD1-9158C616CD1BQ30498664-BB6EB223-7913-4193-8C76-103D3BA38E83Q33627982-B6045762-21EE-4CE6-9E20-C14EE9182091Q33780335-F8716A03-BCE3-4BCE-A67C-6E7B229D5EF8Q33836942-403E2D30-74FD-4722-8156-F4EDCF196977Q34130806-8317BF2E-6309-4C3D-BFB7-55B4751F0493Q34285849-D8BD7B28-3FD9-46EA-8B61-403229C6C9A5Q34389461-693AA247-A383-470D-A440-1DF0998843AAQ34547466-F23E5004-CCB9-4157-8544-6AEF76190717Q34957441-1A662DA1-DA36-44E5-84F5-18FEDBEE5258Q35545909-8C78821A-FB89-489E-8EFC-12C40768F7BBQ35587423-57B298A2-E2CF-451F-B637-4F7587786C4DQ35806742-DEB12D4A-67F7-4783-B0A3-D6AE7DE803F8Q36067388-F199C56C-702D-4A22-889A-74915F2360E4Q36072445-7D3E6312-6D6C-484B-BB56-4EDA042B4ABAQ36157523-8A9BFF00-4023-4161-A75F-10594DFD11D1Q36206178-291FF876-7C69-4D7D-B58B-F0B30C9E86CDQ36444472-355F7A46-2A80-45DD-B3FD-AE0A15FE6C19Q36465314-F49CC09A-C8CA-41F7-8A24-8110BAE22941Q36576487-40D76C7F-1312-454B-B089-70E16E013B63Q36678453-A4C2C529-B369-44CC-9EEC-5CEFC07088FBQ36919403-1C785A8F-40ED-4388-A7F9-3028C9537BBDQ36997157-9C86E560-4C35-47EC-A75B-5E1F884127CDQ37137351-27DDA11B-0F91-4446-A164-2194FFA5712EQ37143217-76B451F5-09CE-48C9-B145-9A4567CF294FQ37248811-F9B71AD6-7080-4ECA-A784-978CDEF1AF12Q37401280-37C5D9B7-3427-4595-96E1-B2F1EB183481Q37578801-C9E3C028-F41D-4AB5-A6A9-B61A72939FB5Q37812319-3809240E-D4E7-4410-B0A3-854A69D20AFCQ38040993-11DE99E8-BDF2-4051-9BA3-C82144A48786Q38192968-5EDEAE9C-8B4B-4AB1-8578-2C2742870B41Q38322767-D9E02A1D-0388-4999-8042-A95D3865CFC9Q38793420-36C437D1-8205-4847-B2A5-EA256B17B700Q39216202-CCAE5DD0-7148-42D8-961D-C1D18887EB56Q39737653-BB0C12F5-6CB7-485A-97FA-31D8403FA20CQ41113531-5DE9A23C-A9E8-45EE-BF87-5DD455042DA1
P2860
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Age-related microglial activat ...... odegeneration in C57BL/6 mice.
@en
Age-related microglial activat ...... odegeneration in C57BL/6 mice.
@nl
type
label
Age-related microglial activat ...... odegeneration in C57BL/6 mice.
@en
Age-related microglial activat ...... odegeneration in C57BL/6 mice.
@nl
prefLabel
Age-related microglial activat ...... odegeneration in C57BL/6 mice.
@en
Age-related microglial activat ...... odegeneration in C57BL/6 mice.
@nl
P2093
P1433
P1476
Age-related microglial activat ...... odegeneration in C57BL/6 mice.
@en
P2093
Byung Pil Cho
David S Albers
Lichuan Yang
Lorraine A DeGiorgio
M Flint Beal
Shuei Sugama
Stefan Lorenzl
Tong H Joh
P304
P356
10.1016/S0006-8993(02)04085-4
P407
P577
2003-02-01T00:00:00Z